Kadiri and colleagues demonstrated that the rate of hypoglycemia was halved and 2-h postprandial glucose was lower after Iftar (fast-breaking meal) when using insulin lispro compared with regular human insulin in individuals with T1DM treated with basal isophane insulin who fasted during Ramadan (15); albeit risk of hypoglycemia persisting. The gene discussed is INS; the disease is Hypoglycemia.